Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis

Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis

Summary

ICD Research's Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.

Key Findings

This report is a crucial resource for industry executives and anyone looking to access key information about Hypermarcas SA

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis

Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.

This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

The SWOT analysis identifies the company’s strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Reasons To Buy

Quickly enhance your understanding of Hypermarcas SA

Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

Increase business/sales activities by understanding your competitors’ businesses better.

Recognize potential partnerships and suppliers.

Key Highlights

Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.


1 Hypermarcas SA - Key Employees
2 Hypermarcas SA - Major Products and Services
3 Hypermarcas SA - History
4 Hypermarcas SA - Company Statement
5 Hypermarcas SA - Locations and Subsidiaries
5.1 Hypermarcas SA - Head Office
5.2 Hypermarcas SA - Other Locations and Subsidiaries
6 Hypermarcas SA - Business Analysis
6.1 Hypermarcas SA - Company Overview
6.2 Hypermarcas SA - Business Description
7 Hypermarcas SA - SWOT Analysis
7.1 Hypermarcas SA - SWOT Analysis - Overview
7.2 Hypermarcas SA - Strengths
7.2.1 Strength - Strengthening Liquidity Position
7.2.2 Strength - Strong Financial Performance
7.2.3 Strength - Diverse Brands and Product Portfolio
7.3 Hypermarcas SA - Weaknesses
7.3.1 Weakness - Overdependence on Brazilian market
7.4 Hypermarcas SA - Opportunities
7.4.1 Opportunity - New Product Launch
7.4.2 Opportunity - Growing Pharmaceutical Market
7.4.3 Opportunity - Business Reorganization
7.5 Hypermarcas SA - Threats
7.5.1 Threat - Declining Economy of Brazil
7.5.2 Threat - Competitive Landscape
7.5.3 Threat - Industry Regulations
8 Hypermarcas SA - Company Financial Analysis
8.1 Hypermarcas SA - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
9 Hypermarcas SA - Interim ratios
9.1.1 Hypermarcas SA - Financial ratios: Capital Market Ratios
9.2 Hypermarcas SA - Financial Performance and Ratio Charts
9.2.1 Hypermarcas SA - Revenue and Operating margin
9.2.2 Hypermarcas SA - Asset and Liabilities
9.2.3 Hypermarcas SA - Net Debt vs. Gearing Ratio
9.2.4 Hypermarcas SA - Operational Efficiency
9.2.5 Hypermarcas SA - Solvency
9.2.6 Hypermarcas SA - Valuation
9.3 Hypermarcas SA - Competitive Benchmarking
9.3.1 Hypermarcas SA - Market Capitalization
9.3.2 Hypermarcas SA - Efficiency
9.3.3 Hypermarcas SA - Valuation
9.3.4 Hypermarcas SA - Turnover: Inventory and Asset
9.3.5 Hypermarcas SA - Liquidity
10 Hypermarcas SA - Mergers & Acquisitions and Partnerships
10.1 Hypermarcas SA - M&A and Partnerships Strategy
11 Hypermarcas SA - Recent Developments
12 Appendix
12.1 Methodology
12.2 Hypermarcas SA - Ratio Definitions
12.3 Disclaimer
List of Tables
Table 1: Hypermarcas SA - Key Employees
Table 2: Hypermarcas SA - Major Products and Services
Table 3: Hypermarcas SA - History
Table 4: Hypermarcas SA - Subsidiaries
Table 5: Hypermarcas SA - Annual ratios
Table 6: Hypermarcas SA - Interim ratios
Table 7: Hypermarcas SA - Capital Market Ratios
List of Figures
Figure 1: Hypermarcas SA - Revenue and Operating Profit
Figure 2: Hypermarcas SA - Asset and Liabilities
Figure 3: Hypermarcas SA - Net Debt vs. Gearing Ratio
Figure 4: Hypermarcas SA - Operational Efficiency
Figure 5: Hypermarcas SA - Solvency
Figure 6: Hypermarcas SA - Valuation
Figure 7: Hypermarcas SA - Market Capitalization
Figure 8: Hypermarcas SA - Efficiency
Figure 9: Hypermarcas SA - Valuation
Figure 10: Hypermarcas SA - Turnover: Inventory and Asset
Figure 11: Hypermarcas SA - Liquidity

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook